長期投資家のためのIR情報
バリュートレンド

【4936】アクシージア
化粧品及びサプリメント製造・販売事業
類似企業:
【業界1位】 花王

売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)
対前回 修正率 修正率 営業利益
(百万円)
対前回 修正率 修正率 経常利益
(百万円)
対前回 修正率 修正率 当期利益
(百万円)
対前回 修正率 修正率
2027.07 2026/09/14 当初予 14,800 - - - -50 - - - -100 - - - -185 - - -
2026.07 2026/09/14 実 13,466 ↓ -0.3% -6.7% -176 ↑ +29.6% -130.9% 23 ↑ +167.6% -95.9% -464 ↓ -341.9% -225.4%
2026.07 2026/06/12 Q3予 13,500 ↓ -6.5% -6.5% -250 ↓ -143.9% -143.9% -34 ↓ -106.1% -106.1% -105 ↓ -128.4% -128.4%
2026.07 2026/03/13 Q2予 14,440 → 0.0% 0.0% 570 → 0.0% 0.0% 560 → 0.0% 0.0% 370 → 0.0% 0.0%
2026.07 2025/12/15 Q1予 14,440 → 0.0% 0.0% 570 → 0.0% 0.0% 560 → 0.0% 0.0% 370 → 0.0% 0.0%
2026.07 2025/09/12 当初予 14,440 - - - 570 - - - 560 - - - 370 - - -
2025.07 2025/09/12 実 13,478 ↓ -0.0% -12.6% 513 ↓ -7.9% -45.5% 504 ↓ -8.0% -44.4% 320 ↓ -9.6% -49.7%
2025.07 2025/09/08 修正予 13,479 ↑ +1.5% -12.6% 557 ↑ +26.6% -40.8% 548 ↑ +61.2% -39.5% 354 ↑ +152.9% -44.3%
2025.07 2025/06/13 Q3予 13,281 → 0.0% -13.9% 440 ↑ +112.6% -53.2% 340 ↑ +83.8% -62.5% 140 ↑ +26.1% -78.0%
2025.07 2025/03/14 Q2予 13,281 ↓ -13.9% -13.9% 207 ↓ -78.0% -78.0% 185 ↓ -79.6% -79.6% 111 ↓ -82.5% -82.5%
2025.07 2024/12/13 Q1予 15,417 → 0.0% 0.0% 941 → 0.0% 0.0% 906 → 0.0% 0.0% 636 → 0.0% 0.0%
2025.07 2024/09/13 当初予 15,417 - - - 941 - - - 906 - - - 636 - - -
2024.07 2024/09/13 実 12,192 ↓ -0.1% -6.2% 918 ↑ +10.6% -61.7% 1,122 ↑ +7.9% -51.2% 794 ↑ +13.4% -51.4%
2024.07 2024/06/14 Q3予 12,200 ↑ +7.0% -6.2% 830 ↑ +12.2% -65.4% 1,040 ↑ +30.0% -54.8% 700 ↑ +32.1% -57.2%
2024.07 2024/03/14 Q2予 11,400 ↓ -12.3% -12.3% 740 ↓ -69.2% -69.2% 800 ↓ -65.2% -65.2% 530 ↓ -67.6% -67.6%
2024.07 2023/12/15 Q1予 13,000 → 0.0% 0.0% 2,400 → 0.0% 0.0% 2,300 → 0.0% 0.0% 1,635 → 0.0% 0.0%
2024.07 2023/09/14 当初予 13,000 - - - 2,400 - - - 2,300 - - - 1,635 - - -
2023.07 2023/09/14 実 11,341 ↑ +9.6% +9.6% 1,899 ↑ +4.5% +4.5% 1,902 ↑ +5.8% +5.8% 1,330 ↑ +13.5% +13.5%
2023.07 2023/06/12 Q3予 10,351 → 0.0% 0.0% 1,818 → 0.0% 0.0% 1,797 → 0.0% 0.0% 1,172 → 0.0% 0.0%
2023.07 2023/03/13 Q2予 10,351 → 0.0% 0.0% 1,818 → 0.0% 0.0% 1,797 → 0.0% 0.0% 1,172 → 0.0% 0.0%
2023.07 2022/12/12 Q1予 10,351 → 0.0% 0.0% 1,818 → 0.0% 0.0% 1,797 → 0.0% 0.0% 1,172 → 0.0% 0.0%
2023.07 2022/09/14 当初予 10,351 - - - 1,818 - - - 1,797 - - - 1,172 - - -
2022.07 2022/09/14 実 8,215 ↑ +2.7% +15.4% 1,633 ↑ +8.9% +11.4% 1,746 ↑ +9.1% +22.6% 1,116 ↑ +6.3% +20.0%
2022.07 2022/07/14 修正予 8,000 ↑ +12.4% +12.4% 1,500 ↑ +2.3% +2.3% 1,600 ↑ +12.4% +12.4% 1,050 ↑ +12.9% +12.9%
2022.07 2022/06/29 Q3予 7,117 → 0.0% 0.0% 1,466 → 0.0% 0.0% 1,424 → 0.0% 0.0% 930 → 0.0% 0.0%
2022.07 2022/03/11 Q2予 7,117 → 0.0% 0.0% 1,466 → 0.0% 0.0% 1,424 → 0.0% 0.0% 930 → 0.0% 0.0%
2022.07 2021/12/10 Q1予 7,117 → 0.0% 0.0% 1,466 → 0.0% 0.0% 1,424 → 0.0% 0.0% 930 → 0.0% 0.0%
2022.07 2021/09/13 当初予 7,117 - - - 1,466 - - - 1,424 - - - 930 - - -
2021.07 2021/09/13 実 5,787 ↑ +3.3% +11.9% 1,383 ↑ +2.4% +7.8% 1,370 ↑ +1.5% +9.4% 868 ↑ +2.1% -1.7%
2021.07 2021/06/10 Q3予 5,600 ↑ +8.3% +8.3% 1,350 ↑ +5.2% +5.2% 1,350 ↑ +7.8% +7.8% 850 ↓ -3.7% -3.7%
2021.07 2021/03/10 当初予 5,172 - - - 1,283 - - - 1,252 - - - 883 - - -
シェア ツイート
ページトップへ戻る